nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—Masoprocol—IGF1R—adrenal gland cancer	0.0726	0.758	CrCbGaD
L-DOPA—PSIP1—gonad—adrenal gland cancer	0.0256	0.118	CbGeAlD
L-DOPA—PSIP1—pituitary gland—adrenal gland cancer	0.025	0.115	CbGeAlD
L-DOPA—PSIP1—adrenal gland—adrenal gland cancer	0.0223	0.103	CbGeAlD
L-DOPA—CYP2D6—urine—adrenal gland cancer	0.0174	0.0798	CbGeAlD
L-DOPA—SLC7A8—gonad—adrenal gland cancer	0.0169	0.0776	CbGeAlD
L-DOPA—SLC7A8—pituitary gland—adrenal gland cancer	0.0165	0.0757	CbGeAlD
L-DOPA—SLC7A8—adrenal gland—adrenal gland cancer	0.0147	0.0676	CbGeAlD
L-DOPA—SLC7A5—gonad—adrenal gland cancer	0.0131	0.0601	CbGeAlD
L-DOPA—SLC7A5—cardiac atrium—adrenal gland cancer	0.0131	0.06	CbGeAlD
L-DOPA—SLC7A5—pituitary gland—adrenal gland cancer	0.0128	0.0586	CbGeAlD
L-DOPA—DDC—adrenal gland—adrenal gland cancer	0.0127	0.0585	CbGeAlD
L-DOPA—SLC7A5—adrenal gland—adrenal gland cancer	0.0114	0.0524	CbGeAlD
L-DOPA—SLC16A10—gonad—adrenal gland cancer	0.01	0.046	CbGeAlD
L-DOPA—Aminosalicylic Acid—PTGS2—adrenal gland cancer	0.00983	0.103	CrCbGaD
L-DOPA—Mesalazine—PTGS2—adrenal gland cancer	0.00771	0.0805	CrCbGaD
L-DOPA—DRD2—pituitary gland—adrenal gland cancer	0.00619	0.0284	CbGeAlD
L-DOPA—Liothyronine—ABCB1—adrenal gland cancer	0.00564	0.0589	CrCbGaD
L-DOPA—SLC7A5—Hemostasis—CDC42—adrenal gland cancer	0.00287	0.00418	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00286	0.00417	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00285	0.00415	CbGpPWpGaD
L-DOPA—DDC—Metabolism—SDHB—adrenal gland cancer	0.0028	0.00408	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00279	0.00406	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—IGF2—adrenal gland cancer	0.00277	0.00403	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—GNAS—adrenal gland cancer	0.00274	0.004	CbGpPWpGaD
L-DOPA—SLC7A8—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00272	0.00397	CbGpPWpGaD
L-DOPA—SLC7A8—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00267	0.00389	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00259	0.00377	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00255	0.00372	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00246	0.00358	CbGpPWpGaD
L-DOPA—PSIP1—Disease—CDC42—adrenal gland cancer	0.00244	0.00356	CbGpPWpGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00242	0.00352	CbGpPWpGaD
L-DOPA—SLC7A5—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00238	0.00346	CbGpPWpGaD
L-DOPA—SLC7A5—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00233	0.0034	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00232	0.00337	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00227	0.00331	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00221	0.00322	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00219	0.00319	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—TSHR—adrenal gland cancer	0.00219	0.00319	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00218	0.00318	CbGpPWpGaD
L-DOPA—DRD1—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00213	0.0031	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0021	0.00306	CbGpPWpGaD
L-DOPA—DRD4—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.0021	0.00306	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00209	0.00304	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00206	0.003	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00197	0.00287	CbGpPWpGaD
L-DOPA—PSIP1—Disease—TERT—adrenal gland cancer	0.00196	0.00285	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00195	0.00285	CbGpPWpGaD
L-DOPA—SLC16A10—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00195	0.00284	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—TSHR—adrenal gland cancer	0.00194	0.00283	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00189	0.00276	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00188	0.00274	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00187	0.00272	CbGpPWpGaD
L-DOPA—DRD3—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00187	0.00272	CbGpPWpGaD
L-DOPA—DDC—Metabolism—RRM1—adrenal gland cancer	0.00181	0.00263	CbGpPWpGaD
L-DOPA—DDC—Metabolism—SDHD—adrenal gland cancer	0.00181	0.00263	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—GNAS—adrenal gland cancer	0.00172	0.00251	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00171	0.00249	CbGpPWpGaD
L-DOPA—PSIP1—Disease—BAD—adrenal gland cancer	0.0017	0.00248	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—GNRHR—adrenal gland cancer	0.00168	0.00245	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00168	0.00244	CbGpPWpGaD
L-DOPA—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00167	0.00244	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00167	0.00243	CbGpPWpGaD
L-DOPA—SLC16A10—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00158	0.0023	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00157	0.00229	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00157	0.00228	CbGpPWpGaD
L-DOPA—PSIP1—Disease—BRAF—adrenal gland cancer	0.00155	0.00226	CbGpPWpGaD
L-DOPA—SLC16A10—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00155	0.00226	CbGpPWpGaD
L-DOPA—DRD5—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00153	0.00222	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—TSHR—adrenal gland cancer	0.00152	0.00222	CbGpPWpGaD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00151	0.0022	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00149	0.00217	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00147	0.00214	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00143	0.00208	CbGpPWpGaD
L-DOPA—DRD2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00143	0.00208	CbGpPWpGaD
L-DOPA—DRD4—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00142	0.00206	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00139	0.00202	CbGpPWpGaD
L-DOPA—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00136	0.00198	CbGpPWpGaD
L-DOPA—DDC—Metabolism—MED12—adrenal gland cancer	0.00135	0.00196	CbGpPWpGaD
L-DOPA—DDC—Circadian rythm related genes—TP53—adrenal gland cancer	0.00131	0.00191	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—GNAS—adrenal gland cancer	0.00127	0.00185	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00126	0.00184	CbGpPWpGaD
L-DOPA—DRD3—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00126	0.00183	CbGpPWpGaD
L-DOPA—PSIP1—Disease—PTGS2—adrenal gland cancer	0.00125	0.00183	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00125	0.00182	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—GNRHR—adrenal gland cancer	0.00124	0.00181	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00124	0.0018	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00123	0.0018	CbGpPWpGaD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00123	0.00179	CbGpPWpGaD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.0012	0.00175	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—POMC—adrenal gland cancer	0.00116	0.00169	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00116	0.00168	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00115	0.00167	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00113	0.00165	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00113	0.00165	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00113	0.00164	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—TSHR—adrenal gland cancer	0.00112	0.00164	CbGpPWpGaD
L-DOPA—PSIP1—Disease—CTNNB1—adrenal gland cancer	0.00112	0.00163	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00112	0.00163	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00112	0.00163	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00111	0.00162	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—GNRHR—adrenal gland cancer	0.0011	0.00161	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0011	0.0016	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00109	0.00159	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00109	0.00158	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00104	0.00151	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00103	0.00149	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00102	0.00149	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00101	0.00148	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00101	0.00147	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—GNRH1—adrenal gland cancer	0.00101	0.00147	CbGpPWpGaD
L-DOPA—SLC7A8—Hemostasis—TP53—adrenal gland cancer	0.00101	0.00146	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.001	0.00146	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—TSHR—adrenal gland cancer	0.000998	0.00145	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PRKACA—adrenal gland cancer	0.000982	0.00143	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000978	0.00142	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000975	0.00142	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000965	0.00141	CbGpPWpGaD
L-DOPA—DRD2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000962	0.0014	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000943	0.00137	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CDC42—adrenal gland cancer	0.000926	0.00135	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—SPRY2—adrenal gland cancer	0.000922	0.00134	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TSHR—adrenal gland cancer	0.000899	0.00131	CbGpPWpGaD
L-DOPA—PSIP1—Disease—EGFR—adrenal gland cancer	0.000889	0.00129	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—GNAS—adrenal gland cancer	0.000885	0.00129	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—TP53—adrenal gland cancer	0.000877	0.00128	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—GNAS—adrenal gland cancer	0.000865	0.00126	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—POMC—adrenal gland cancer	0.000857	0.00125	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000856	0.00125	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MEN1—adrenal gland cancer	0.000845	0.00123	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GNRHR—adrenal gland cancer	0.000845	0.00123	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000841	0.00122	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000806	0.00117	CbGpPWpGaD
L-DOPA—DDC—Metabolism—GNAS—adrenal gland cancer	0.000796	0.00116	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000785	0.00114	CbGpPWpGaD
L-DOPA—DDC—Metabolism—ABCB1—adrenal gland cancer	0.000781	0.00114	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—POMC—adrenal gland cancer	0.000772	0.00112	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000765	0.00111	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—TSHR—adrenal gland cancer	0.000763	0.00111	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—TP53—adrenal gland cancer	0.000762	0.00111	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—POMC—adrenal gland cancer	0.000761	0.00111	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000753	0.0011	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—GNRH1—adrenal gland cancer	0.000744	0.00108	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000738	0.00108	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000726	0.00106	CbGpPWpGaD
L-DOPA—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.00072	0.00105	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000719	0.00105	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000716	0.00104	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—TP53—adrenal gland cancer	0.000686	0.000999	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CDC42—adrenal gland cancer	0.000684	0.000996	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—SPRY2—adrenal gland cancer	0.000681	0.000992	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000678	0.000987	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—TP53—adrenal gland cancer	0.000676	0.000985	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00067	0.000976	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000669	0.000974	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TSHR—adrenal gland cancer	0.000663	0.000966	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—GNRH1—adrenal gland cancer	0.000661	0.000963	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—POMC—adrenal gland cancer	0.000656	0.000956	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—GNAS—adrenal gland cancer	0.000653	0.000952	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000648	0.000943	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PRKACA—adrenal gland cancer	0.000645	0.00094	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.000644	0.000938	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000639	0.000931	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MEN1—adrenal gland cancer	0.000624	0.000909	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000615	0.000897	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000613	0.000893	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CDC42—adrenal gland cancer	0.000607	0.000885	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—SPRY2—adrenal gland cancer	0.000605	0.000881	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TSHR—adrenal gland cancer	0.000597	0.00087	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—POMC—adrenal gland cancer	0.000596	0.000868	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TSHR—adrenal gland cancer	0.000589	0.000858	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000588	0.000857	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—POMC—adrenal gland cancer	0.000583	0.000849	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—GNAS—adrenal gland cancer	0.00058	0.000845	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MEN1—adrenal gland cancer	0.000562	0.000818	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MEN1—adrenal gland cancer	0.000554	0.000807	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000548	0.000798	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CDC42—adrenal gland cancer	0.000547	0.000797	CbGpPWpGaD
L-DOPA—DDC—Metabolism—POMC—adrenal gland cancer	0.000536	0.00078	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IGF2—adrenal gland cancer	0.000527	0.000768	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—GNAS—adrenal gland cancer	0.000523	0.000762	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—TP53—adrenal gland cancer	0.000518	0.000754	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000512	0.000745	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IGF1R—adrenal gland cancer	0.00051	0.000743	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000506	0.000737	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000489	0.000712	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—POMC—adrenal gland cancer	0.000484	0.000706	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PRKACA—adrenal gland cancer	0.000476	0.000694	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000465	0.000677	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000463	0.000674	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TSHR—adrenal gland cancer	0.000451	0.000657	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000444	0.000647	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—POMC—adrenal gland cancer	0.00044	0.000641	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TERT—adrenal gland cancer	0.000439	0.000639	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000436	0.000635	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—POMC—adrenal gland cancer	0.00043	0.000627	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000429	0.000624	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PTGS2—adrenal gland cancer	0.000427	0.000623	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MEN1—adrenal gland cancer	0.000424	0.000618	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000423	0.000616	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000415	0.000605	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000415	0.000605	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CDC42—adrenal gland cancer	0.000404	0.000588	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—POMC—adrenal gland cancer	0.000396	0.000577	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—POMC—adrenal gland cancer	0.000391	0.000569	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IGF2—adrenal gland cancer	0.000389	0.000567	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—GNAS—adrenal gland cancer	0.000386	0.000562	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—BAD—adrenal gland cancer	0.000382	0.000556	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IGF1R—adrenal gland cancer	0.000376	0.000548	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CDC42—adrenal gland cancer	0.000364	0.00053	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CDC42—adrenal gland cancer	0.000359	0.000523	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—POMC—adrenal gland cancer	0.000352	0.000513	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IGF2—adrenal gland cancer	0.00035	0.00051	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—BRAF—adrenal gland cancer	0.000348	0.000506	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—GNAS—adrenal gland cancer	0.000347	0.000506	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IGF2—adrenal gland cancer	0.000346	0.000504	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—GNAS—adrenal gland cancer	0.000343	0.000499	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000339	0.000494	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—EGFR—adrenal gland cancer	0.000337	0.000491	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000334	0.000487	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000329	0.00048	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TERT—adrenal gland cancer	0.000324	0.000472	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000324	0.000471	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000309	0.000451	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	0.000299	0.000435	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TERT—adrenal gland cancer	0.000292	0.000425	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TERT—adrenal gland cancer	0.000288	0.000419	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—BAD—adrenal gland cancer	0.000282	0.000411	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	0.000275	0.0004	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	0.000265	0.000385	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	0.000262	0.000382	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—POMC—adrenal gland cancer	0.00026	0.000378	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—BRAF—adrenal gland cancer	0.000257	0.000374	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000256	0.000373	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—BAD—adrenal gland cancer	0.000254	0.00037	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000251	0.000366	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—BAD—adrenal gland cancer	0.00025	0.000365	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000249	0.000362	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—POMC—adrenal gland cancer	0.000234	0.000341	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—BRAF—adrenal gland cancer	0.000231	0.000336	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—POMC—adrenal gland cancer	0.000231	0.000336	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—BRAF—adrenal gland cancer	0.000228	0.000332	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000226	0.000329	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000224	0.000326	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000221	0.000322	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TERT—adrenal gland cancer	0.00022	0.000321	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—EGFR—adrenal gland cancer	0.000199	0.00029	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—BAD—adrenal gland cancer	0.000192	0.000279	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000185	0.00027	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000183	0.000267	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.00018	0.000262	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—POMC—adrenal gland cancer	0.000177	0.000257	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	0.000174	0.000254	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000169	0.000246	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TP53—adrenal gland cancer	0.000167	0.000243	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000167	0.000243	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000165	0.00024	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—EGFR—adrenal gland cancer	0.000147	0.000214	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—EGFR—adrenal gland cancer	0.000132	0.000193	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—EGFR—adrenal gland cancer	0.000131	0.00019	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000126	0.000184	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TP53—adrenal gland cancer	0.000123	0.00018	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—POMC—adrenal gland cancer	0.000123	0.000179	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TP53—adrenal gland cancer	0.000111	0.000162	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TP53—adrenal gland cancer	0.00011	0.00016	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	9.99e-05	0.000145	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	9.83e-05	0.000143	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TP53—adrenal gland cancer	8.38e-05	0.000122	CbGpPWpGaD
